Staar Surgical Analyst Ratings
Buy Rating Affirmed for Staar Surgical Amidst Growth Potential and Market Headwinds
Staar Surgical Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Krystal Biotech (KRYS) and Bristol-Myers Squibb (BMY)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA) and Elanco Animal Health (ELAN)
Staar Surgical: A Hold Rating Amid Mixed Performance and Cautious 2024 Outlook
Analysts Conflicted on These Healthcare Names: Schrodinger (SDGR), Accelerate Diagnostics (AXDX) and Staar Surgical (STAA)
BTIG Keeps Their Hold Rating on Staar Surgical (STAA)
BTIG Sticks to Its Hold Rating for Staar Surgical (STAA)
Analysts Conflicted on These Healthcare Names: Staar Surgical (STAA), Venus Concept (VERO) and Eli Lilly & Co (LLY)
BTIG Sticks to Its Hold Rating for Staar Surgical (STAA)
Staar Surgical Analyst Ratings
Analyst Ratings for Staar Surgical
Morgan Stanley Initiates Coverage On Staar Surgical With Equal-Weight Rating, Announces Price Target of $35
Staar Surgical Analyst Ratings
Piper Sandler Maintains Neutral on Staar Surgical, Lowers Price Target to $40
Staar Surgical Analyst Ratings
The Latest Analyst Ratings for Staar Surgical
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), ModivCare (MODV) and Staar Surgical (STAA)
Needham Maintains Buy on Staar Surgical, Lowers Price Target to $49
No Data